PRELUDE THERAPEUTICS INC (PRLD)
Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Americold Enables Direct-to-Consumer Growth Through Integrated Cold Chain Fulfillment Solutions
Aura Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Brazil’s Court of Appeal Perserves Rulings Favourable to the Autazes Potash Project, Blocks Referral of Appeals to Superior Courts
Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update
Group 1 Automotive Appoints Dave Kimbell to Board of Directors
Energence Utah Partnership Positions Senmiao to Pursue Digital Infrastructure Development, with 100 MW Targeted During the Initial Two-Year Development Phase
Mandatory Cash Dividend/ Distribution:
Asset Acquisitions and Disposals: ANNOUNCEMENT PURSUANT TO RULE 706A
Financial Statements and Related Announcement: Half Yearly Results